The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...
Q3 2024 Earnings Call Transcript December 4, 2024 9:00 AM ETCompany ParticipantsRobert Higginbotham - SVP, Corporate ...
Q3 2024 Earnings Call Transcript December 3, 2024 Torrid Holdings Inc. misses on earnings expectations. Reported EPS is ...
Citi Trends Inc (CTRN) reports robust sales and margin expansion, while addressing operational hurdles and store optimization ...
12h
Kane Biotech Inc (KNBIF) reports a remarkable revenue increase and strategic advancements, despite ongoing financial ...
12h
Torrid Holdings Inc (CURV) reports improved margins and cash flow, while navigating sales declines and macroeconomic impacts.
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Operator Greetings and welcome to the Citi Trends third quarter 2024 earnings call. At this time, all participants are in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback